000 02548nam a2200337Ia 4500
001 CRC00E73494PDF
003 BD-DhSAU
005 20151012144259.0
006 m|||||o||d||||||||
007 cr||||
008 100427s2010 flu sb 001 0 eng d
020 _a9781420073508 (ebook : PDF)
040 _aBD-DhSAU
_cBD-DhSAU
090 _aRS380
_b.K537 2010
092 _a615.19
_bK614
100 1 _aKisaalita, William Ssempa,
_d1953-
245 1 0 _a3D cell-based biosensors in drug discovery programs
_h[electronic resource] :
_bmicrotissue engineering for high throughput screening /
_cWilliam S. Kisaalita.
260 _aBoca Raton [Fla.] :
_bCRC Press,
_c2010.
300 _a466 p.
504 _aIncludes bibliographical references and index.
505 8 _a(Publisher-supplied data) Biosensors and Bioassays -- Target-Driven Drug Discovery -- Comparative Genomics and Proteomics -- Comparative Structure and Function -- Chemical Microenvironmental Factors -- Spatial and Temporal Microenvironmental Factors -- Material Physical Property and Force Microenvironmental Factors -- Proteomics as a Promising Tool in the Search for 3D Biomarkers -- Readout Present and Near Future -- Ready-to-Use Commercial 3D Plates -- Challenges to Adopting 3D Cultures in HTS Programs -- Cases for 3D Cultures in Drug Discovery -- Ideal Case Study Design.
520 _a"This book is based upon cutting-edge research conducted in the authors lab (Cellular Bioengineering), which over the past decade has developed a number of sophisticated techniques to facilitate use of 3D cell based assays or biosensors. This book uses data from peer-reviewed publications to conclusively justify use of 3D cell cultures in cell-based biosensors (assays) for (HTS). The majority of assays performed in accelerated drug discovery processes are biochemical in nature, but there is a growing demand for live cell-based assays. Unlike biochemical ones, cellular assays are functional approximations of in vivo biological conditions and can provide more biologically relevant information"--Provided by publisher.
530 _aAlso available in print edition.
538 _aMode of access: World Wide Web.
650 0 _aPharmaceutical biotechnology.
650 0 _aBiosensors.
650 0 _aHigh throughput screening (Drug development)
655 7 _aElectronic books.
_2lcsh
776 1 _z9781420073492
856 4 0 _uhttp://marc.crcnetbase.com/isbn/9781420073508
_qapplication/PDF
999 _c11064
_d11063